skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Adult remover idioma: Russo remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study
Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study

LYNCH, Thomas J ; BONDARENKO, Igor ; RECK, Martin ; LUFT, Alexander ; SERWATOWSKI, Piotr ; BARLESI, Fabrice ; CHACKO, Raju ; SEBASTIAN, Martin ; NEAL, Joel ; HAOLAN LU ; CUILLEROT, Jean-Marie

Journal of clinical oncology, 2012-06, Vol.30 (17), p.2046-2054 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
2
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial

Fuchs, Charles S, Dr Prof ; Tomasek, Jiri, MD ; Yong, Cho Jae, Prof ; Dumitru, Filip, MD ; Passalacqua, Rodolfo, MD ; Goswami, Chanchal, Prof ; Safran, Howard, Prof ; dos Santos, Lucas Vieira, MD ; Aprile, Giuseppe, MD ; Ferry, David R, Prof ; Melichar, Bohuslav, Prof ; Tehfe, Mustapha, MD ; Topuzov, Eldar, Prof ; Zalcberg, John Raymond, Prof ; Chau, Ian, MD ; Campbell, William, Prof ; Sivanandan, Choondal, MD ; Pikiel, Joanna, MD ; Koshiji, Minori, MD ; Hsu, Yanzhi, PhD ; Liepa, Astra M, PharmD ; Gao, Ling, PhD ; Schwartz, Jonathan D, MD ; Tabernero, Josep, MD

The Lancet (British edition), 2014-01, Vol.383 (9911), p.31-39 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial
Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial

SOCINSKI, Mark A ; BONDARENKO, Igor ; IGLESIAS, Jose L ; RENSCHLER, Markus F ; KARASEVA, Nina A ; MAKHSON, Anatoly M ; VYNNYCHENKO, Igor ; OKAMOTO, Isamu ; HON, Jeremy K ; HIRSH, Vera ; BHAR, Paul ; HUI ZHANG

Journal of clinical oncology, 2012-06, Vol.30 (17), p.2055-2062 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
4
Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects
Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects
Material Type:
Artigo 		Adicionar ao Meu Espaço

Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects

Hod, Moshe, MD ; Damm, Peter, MD, DMSC ; Kaaja, Risto, MD, PhD ; Visser, Gerard H.A., MD, PhD ; Dunne, Fidelma, MD, PhD ; Demidova, Irina, MD, DMSC ; Hansen, Anne-Sofie Pade ; Mersebach, Henriette, MD, PhD

American journal of obstetrics and gynecology, 2008-02, Vol.198 (2), p.186.e1-186.e7 [Periódico revisado por pares]

Philadelphia, PA: Mosby, Inc

Texto completo disponível

Citações Citado por
5
Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial
Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial

Jacobson, Ira M, Prof ; Dore, Gregory J, Prof ; Foster, Graham R, Prof ; Fried, Michael W, Prof ; Radu, Monica, MD ; Rafalsky, Vladimir V, Prof ; Moroz, Larysa, Prof ; Craxi, Antonio, Prof ; Peeters, Monika, MSc ; Lenz, Oliver, PhD ; Ouwerkerk-Mahadevan, Sivi, PhD ; De La Rosa, Guy, MD ; Kalmeijer, Ronald, MD ; Scott, Jane, PhD ; Sinha, Rekha, PhD ; Beumont-Mauviel, Maria, PhD

The Lancet (British edition), 2014-08, Vol.384 (9941), p.403-413 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial

Franz, David Neal, Prof ; Belousova, Elena, MD ; Sparagana, Steven, MD ; Bebin, E Martina, MD ; Frost, Michael, MD ; Kuperman, Rachel, MD ; Witt, Olaf, MD ; Kohrman, Michael H, MD ; Flamini, J Robert, MD ; Wu, Joyce Y, MD ; Curatolo, Paolo, Prof ; de Vries, Petrus J, Prof ; Whittemore, Vicky H, PhD ; Thiele, Elizabeth A, MD ; Ford, James P, MS ; Shah, Gaurav, MD ; Cauwel, Helene, MSc ; Lebwohl, David, MD ; Sahmoud, Tarek, MD ; Jozwiak, Sergiusz, MD

The Lancet (British edition), 2013-01, Vol.381 (9861), p.125-132 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer
Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer

SPIGEL, David R ; ERVIN, Thomas J ; GOVINDAN, Ramaswamy ; PATEL, Taral ; ORLOV, Sergey V ; WERTHEIM, Michael S ; WEI YU ; JIPING ZHA ; YAUCH, Robert L ; PATEL, Premal H ; PHAN, See-Chun ; PETERSON, Amy C ; RAMLAU, Rodryg A ; DANIEL, Davey B ; GOLDSCHMIDT, Jerome H ; BLUMENSCHEIN, George R ; KRZAKOWSKI, Maciej J ; ROBINET, Gilles ; GODBERT, Benoit ; BARLESI, Fabrice

Journal of clinical oncology, 2013-11, Vol.31 (32), p.4105-4114 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
8
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

Navarra, Sandra V, MD ; Guzmán, Renato M, MD ; Gallacher, Alberto E, MD ; Hall, Stephen, MD ; Levy, Roger A, MD ; Jimenez, Renato E, MD ; Li, Edmund K-M, MD ; Thomas, Mathew, MD ; Kim, Ho-Youn, MD ; León, Manuel G, MD ; Tanasescu, Coman, MD ; Nasonov, Eugeny, MD ; Lan, Joung-Liang, MD ; Pineda, Lilia, MD ; Zhong, Z John, PhD ; Freimuth, William, MD ; Petri, Michelle A, MD

The Lancet (British edition), 2011, Vol.377 (9767), p.721-731 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
Tivozanib Versus Sorafenib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma: Results From a Phase III Trial
Tivozanib Versus Sorafenib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma: Results From a Phase III Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Tivozanib Versus Sorafenib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma: Results From a Phase III Trial

MOTZER, Robert J ; NOSOV, Dmitry ; KOGAN, Mikhail ; ALEKSEEV, Boris Y ; STERNBERG, Cora N ; SZCZYLIK, Cezary ; CELLA, David ; IVANESCU, Cristina ; KRIVOSHIK, Andrew ; STRAHS, Andrew ; ESTEVES, Brooke ; BERKENBLIT, Anna ; EISEN, Timothy ; HUTSON, Thomas E ; BONDARENKO, Igor ; LESOVOY, Vladimir ; LIPATOV, Oleg ; TOMCZAK, Piotr ; LYULKO, Oleksiy ; ALYASOVA, Anna ; HARZA, Mihai

Journal of clinical oncology, 2013-10, Vol.31 (30), p.3791-3799 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
10
RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative, Locally Recurrent or Metastatic Breast Cancer
RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative, Locally Recurrent or Metastatic Breast Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative, Locally Recurrent or Metastatic Breast Cancer

ROBERT, Nicholas J ; DIERAS, Véronique ; PHAN, See-Chun ; O'SHAUGHNESSY, Joyce ; GLASPY, John ; BRUFSKY, Adam M ; BONDARENKO, Igor ; LIPATOV, Oleg N ; PEREZ, Edith A ; YARDLEY, Denise A ; CHAN, Stephen Y. T ; XIAN ZHOU

Journal of clinical oncology, 2011-04, Vol.29 (10), p.1252-1260 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (1.185)
  2. Revistas revisadas por pares (5.781)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (6.412)
  2. Anais de Congresso  (2)
  3. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1992  (23)
  2. 1992Até1999  (785)
  3. 2000Até2007  (2.105)
  4. 2008Até2016  (3.233)
  5. Após 2016  (269)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (814)
  2. Japonês  (20)
  3. Búlgaro  (2)
  4. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.